Sekine Ikuo, Nokihara Hiroshi, Yamamoto Noboru, Kunitoh Hideo, Ohe Yuichiro, Tamura Tomohide
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Lung Cancer. 2009 Aug;65(2):219-22. doi: 10.1016/j.lungcan.2008.10.026. Epub 2008 Dec 10.
The purpose of this study was to identify the risk factors for skeletal-related events (SREs) in patients with advanced non-small cell lung cancer (NSCLC). SREs were defined as pathologic fractures, spinal cord compression, requirement for radiation therapy, other radiological intervention, or surgery to the bone, and hypercalcemia of malignancy. Time-to-the first SRE and SRE-free survival, and their associations with the patient characteristics were evaluated retrospectively in 642 patients with metastatic NSCLC who received systemic chemotherapy. A total of 118 (18.4%) patients developed SREs during or after the initial chemotherapy. Of these, 107 required radiotherapy to the bone, 5 developed hypercalcemia of malignancy, 3 developed compression fracture of the vertebrae, 2 required surgical treatment of the bone, and 1 underwent radiofrequency ablation therapy to the bone. The first SRE occurred within 12 months in 80 (67.8%) of the 107 patients. The results of multivariate analysis revealed that male sex, performance status (PS) of 2-3 and multiple bone metastases were risk factors for the first SRE, with hazard ratios (HRs) (95% confidence interval [CI]) to the reference of 1.44 (0.98-2.11), 2.21 (0.97-5.03) and 4.43 (2.91-6.76), respectively. SRE-free survival showed a similar trend. The HRs (CI) of male sex, PS of 2 and multiple bone metastases were 1.64 (1.30-2.06), 3.72 (2.31-5.98) and 1.80 (1.40-2.31), respectively. In conclusion, the presence of multiple bone metastases was significantly associated with the development of SRE in patients with advanced NSCLC treated by systemic chemotherapy. Male sex and poor performance status may be additional risk factors for the development of SREs in these patients.
本研究的目的是确定晚期非小细胞肺癌(NSCLC)患者发生骨相关事件(SREs)的危险因素。SREs被定义为病理性骨折、脊髓压迫、需要进行放射治疗、其他放射学干预或骨手术,以及恶性肿瘤高钙血症。对642例接受全身化疗的转移性NSCLC患者回顾性评估首次发生SRE的时间和无SRE生存期,以及它们与患者特征的关联。共有118例(18.4%)患者在初始化疗期间或之后发生SREs。其中,107例需要进行骨放疗,5例发生恶性肿瘤高钙血症,3例发生椎体压缩性骨折,2例需要进行骨手术治疗,1例接受了骨射频消融治疗。107例患者中有80例(67.8%)在12个月内发生首次SRE。多因素分析结果显示,男性、体能状态(PS)为2 - 3分和多发骨转移是首次发生SRE的危险因素,风险比(HRs)(95%置信区间[CI])相对于参照分别为1.44(0.98 - 2.11)、2.21(0.97 - 5.03)和4.43(2.91 - 6.76)。无SRE生存期显示出类似趋势。男性、PS为2分和多发骨转移的HRs(CI)分别为1.64(1.30 - 2.06)、3.72(2.31 - 5.98)和1.80(1.40 - 2.31)。总之,多发骨转移的存在与接受全身化疗的晚期NSCLC患者发生SRE显著相关。男性和体能状态差可能是这些患者发生SRE的额外危险因素。